A 47-year-old womanwho was homozygousfor a silent cholinesterase gene (hereditary serum cholinesterase deficiency) presented with nephrotic syndrome and hyperlipidemia. Renal biopsy performed in 1986 demonstrated mesangial proliferative glomerulonephritis. Four years later, a second biopsy revealed progression with mesangial interpositions and severe lipid deposition in the glomeruli, tubules and interstitium. This is the first case of hereditary serum cholinesterase deficiency accompanied by renal disease. Serum cholinesterase deficiency may be related to hyperlipidemia and abnormal lipid deposition in the kidney, which promotes the progression of renal disease. (Internal Medicine 32: 145-151 1993) 
Introduction
Hereditary serum cholinesterase (ChE) deficiency is a rare disease that was first described by Forbat and Lehmann in 1953 (1) . Affected patients show a prolonged response to succinylcholine used in anesthesia due to their reduced ability to catabolize this agent. Except for problems with anesthesia, no clinical abnormalities have been reported in individuals with hereditary serum ChE deficiency. While ChE activity has been detected in various organs (2) including the kidney (3, 4) , its biologic function has not been clarified. Recently, ChE activity has been suggested to play a role in lipid metabolism (5, 6) and atherosclerosis (7) .
Wedescribe a patient who had hereditary serum ChE deficiency accompanied by chronic glomerulonephritis with severe lipid deposition. The relationship between serum ChE deficiency and abnormal lipid metabolism in the kidney will be discussed.
Case Report
This 47-year-old womanhad an eight-year history of proteinuria. She had been admitted to the Kidney Center Physical examination revealed mild edema of the lower extremities. There was no xanthoma of the skin.
Blood pressure was 140/85 mmHg.Proteinuria (4.7 g/day) and slight microscopic hematuria (RBC 3/HPF) with occasional lipid droplets and lipid-storing cells in the urine were present. Glycosuria was absent. Serum total protein (4.9 g/dl) and albumin (2.8 g/dl) were decreased, and serum creatinine (0.8 mg/dl) and blood urea nitrogen (10mg/dl) were within the normal range. Serum total cholesterol (307mg/dl) and LDL (1,120mg/dl) were increased. Details of the serum lipid analysis appear in Table 1 . Lecithin cholesterol acyltransferase (LCAT) was within the normal range (56.1 nmol/ml/h). Serum immunoglobulin levels and complement activity were normal. Tests for serum autoantibodies and cryoglobulin were all negative, and serum immunecomplexes showed no elevation. The glomerular nitration rate (GFR) measured by inulin clearance was mildly decreased (67.7 ml/min/1.47 m2 begun in an attempt to reduce the hyperlipidemia and thus to halt the progression of the renal disease. After 6 months of LDLapheresis (a total of 15 sessions), serum LDLremained within the normal range; however, the proteinuria worsened, as summarized in Fig. 1 . The family of the patient is shown in Fig. 2 . There were no consanguineous marriages in her family. Neither renal disease nor hyperlipidemia was found in her family history.
Materials and Methods

1) Measurement of serum ChE activity
Sera obtained from the patient, her four sons and her husband were analyzed. Serum ChE activity was determined by the enzymatic method using a Determiner ChE-S® assay kit (Kyowa Hakko Kogyo Co. Ltd., Tokyo) (8) . Choline was liberated from the substrates (o-toluoylcholine) by ChE and oxidized by choline oxidase to betaine with the simultaneous production of hydrogen peroxide, which was determined using 4-aminoantipyrine and phenol in the presence of peroxidase. After additional incubation at 37°C for 20 minutes, the resultant red color was measured at 500 nmagainst a reagent blank by photoabsorptometry. The reference range of healthy subjects is from 300 to 720 IU/1 using this method.
2) Pathological analysis of renal biopsy specimens The renal tissue specimens obtained at biopsy were Ltd., Japan).
Results
1) Serum ChE activity
The serum ChEactivity of the patient, all of her sons and her husband is shown in Table 2 . The serum ChE activity of the patient was below 1 IU/1 (undetectable). The serum ChEactivity of her first and second sons was decreased (258 and 271IU/1, respectively) but that of her third and fourth sons (twins) was within the normal range (526 and 451 IU/1, respectively). The serum ChE activity of her husband was within the normal range (451 IU/I). Serum total cholesterol, HDLcholesterol and triglyceride values are also shown in Table 2 . The total cholesterol, HDL cholesterol and triglyceride levels of her family were almost normal.
2) Pathology of renal biopsy specimens (a) Light microscopic findings The biopsy specimen obtained in June 1986 contained five glomeruli. Each showed mild proliferation of the mesangial cells and an increase in the mesangial matrix with focal and segmental accentuation. Mesangial interposition was partially seen (Fig. 3) . No abnormalities of the tubules, interstitium and vessels were found. were frequently seen and the glomerular capillary lumina were generally obscured. Exudative changes such as fibrin caps were occasionally seen in the paramesangial area and the glomerular capillary tufts (Fig. 4) . Sudan
Black B staining of the frozen sections revealed that these foam cells contained neutral lipid substances and, furthermore, that the fine vacuolar changes in the mesangium were caused by lipid deposition (Fig. 5) . Foamydegeneration of the tubular cells and foam cells in the interstitium were frequent findings (Fig. 6 ).
(b) Immunohistochemical findings
Immunofluorescent examination of the frozen sections demonstrated that granular and lumpy staining of IgG (Fig. 7) , IgA, IgM, Clq and C3 was present predominantly along the capillary walls and partially in the mesangium. These findings were also observed at the first biopsy, but the lumpy staining along the capillary wall was not as conspicuous as that seen at the second biopsy. At the second biopsy, intense and granular staining of apolipoprotein (apo) B was present both in the mesangium and along the capillary walls (Fig. 8) . The deposition of apo E followed the same pattern as that of apo B. (c) Electron microscopic findings Electron microscopic examination of the second biopsy specimen revealed frequent electron-dense deposits of various sizes in the capillary walls and mesangium of the glomerulus. The deposits in the capillary walls, seen more frequently, were usually present in the subendothelial spaces, but sometimes extended into the intramembranous and subepithelial spaces of the GBM. Myelin-like figures were sometimes seen in the mesangial cells (Fig. 9) . Vacuolar formation was observed in the mesangial cells (Fig. 10) . At the first renal biopsy, similar electron deposits were seen in the capillary walls and mesangium, but not as frequently as at the second biopsy. Vacuolar changes in the mesangial cells and infiltration of the foamy macrophages were not seen in the first biopsy specimen. proteins. Although we cannot determine whether the hyperlipidemia seen in the present case should be ascribed to the secondary effects of nephrotic syndromeor serum ChE deficiency, the presence of hyperlipidemia during the early period before the degree of proteinuria reached the nephrotic range suggests the latter possibility. Hyperlipidemia is thought to exacerbate the progression of glomerular sclerosis by the accumulation of lipids in the glomerular tissue (12). This hypothesis is supported by various clinical observations and experimental models. In the kidney, serum LDLcan be taken up by the LDLreceptors that exist in glomerular endothelial cells (13), epithelial cells (14) (18) . In the present patient, the LCATactivity was normal, and no abnormal deposition of lipids was detected in various organs such as the liver, spleen and heart. Recently, an unusual glomerulopathy with lipid deposition, termed "lipoprotein glomerulopathy", was reported as a new renal disease that was presumably induced by abnormal lipid metabolism (19). Histologically, the above-mentioned condition is characterized by marked dilatation of the glomerular capillary lumina and the presence of lipoprotein thrombi within the lumima. The serum apolipoprotein profile revealed a high level of apo E. In the present case however, neither marked dilatation of the capillary lumina nor lipoprotein thrombi were observed, and serum apo E was not elevated, thus excluding the diagnosis of lipoprotein glomerulopathy.
Discussion
LDLapheresis removes the serum LDLsby extracorporeal circulation and is useful in patients with familial hypercholesterolemia (20). Recently, this treatment has also been given to patients with focal glomerulosclerosis (FGS) , and it has proved effective in some cases (21).
In the present patient, LDLapheresis was performed 15 times combinedwith the administration of pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (HMG-CoA inhibitor), probucol and cholestyramine for 6 months. Although the serum LDLlevel of the patient fell and was maintained within the normal range, her proteinuria worsened. This suggests that the normalization of serum LDLfor a short period of time did not lead to the remission of renal disease, and that other factors in addition to serum LDLregulate the pathogenesis of lipid-induced glomerular injury.
